VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹136 Cr | ₹79 Cr | ₹83 Cr | ₹93 Cr | ₹97 Cr |
What is the latest Total Current Liabilities ratio of VENUS REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹136 Cr |
| Mar2024 | ₹79 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹93 Cr |
| Mar2021 | ₹97 Cr |
How is Total Current Liabilities of VENUS REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹136 Cr | 71.61 | |
| Mar2024 | ₹79 Cr | -3.82 | |
| Mar2023 | ₹83 Cr | -10.97 | |
| Mar2022 | ₹93 Cr | -4.83 | |
| Mar2021 | ₹97 Cr | - | |
Compare Total Current Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,382.1 Cr | 13% | 0.9% | 203.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹453,750.0 Cr | 0.6% | 13.6% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,117.0 Cr | 1.5% | 9.1% | 9.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,314.0 Cr | 1.5% | 8.2% | 35.7% | Stock Analytics | |
| CIPLA | ₹113,225.0 Cr | -2.1% | 13.7% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,037.0 Cr | -1.4% | 8% | 7.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 13% |
0.9% |
203.4% |
| SENSEX | -0.3% |
-4.3% |
-8.9% |
You may also like the below Video Courses